Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti–Type I Interferon Antibodies - Top-Institutions - MDSpire

Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti–Type I Interferon Antibodies

  • By

  • Federica Barzaghi

  • Camilla Visconti

  • Giovanni Battista Pipitone

  • Simone Bondesan

  • Giulia Molli

  • Stefania Giannelli

  • Claudia Sartirana

  • Vito Lampasona

  • Elena Bazzigaluppi

  • Cristina Brigatti

  • Adrian Gervais

  • Paul Bastard

  • Chiara Tassan Din

  • Chiara Molinari

  • Lorenzo Piemonti

  • Jean-Laurent Casanova

  • Paola Carrera

  • Giorgio Casari

  • Alessandro Aiuti

  • July 8, 2024

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Virology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Neurology

  • #3

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Genetics

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Immunology
    • Infectious Diseases
    • Oncology

  • #5

    Massachusetts General Hospital (MGH), Harvard Medical School
    Massachusetts General Hospital (MGH), Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Genetics

Original Source(s)

Severe West Nile Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in a Patient With Thymoma and Anti–Type I Interferon Antibodies

  • by Federica Barzaghi, Camilla Visconti, Giovanni Battista Pipitone, Simone Bondesan, Giulia Molli, Stefania Giannelli, Claudia Sartirana, Vito Lampasona, Elena Bazzigaluppi, Cristina Brigatti, Adrian Gervais, Paul Bastard, Chiara Tassan Din, Chiara Molinari, Lorenzo Piemonti, Jean-Laurent Casanova, Paola Carrera, Giorgio Casari, Alessandro Aiuti

  • July 8, 2024

Related Content

Associated thromboembolic events to the post COVID syndrome: a systematic review and meta-analysis

COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice

Tennessee's Ivermectin Experiment

Pharmacies expand access as oversight questions grow.